Impact of a Specialized Team in Diabetes on Glucometric Parameters and Efficiency Indicators During Hospital Admission in Medical Units.

IF 5.7 2区医学 Q1 ENDOCRINOLOGY & METABOLISM

Diabetes technology & therapeutics Pub Date : 2025-07-23 DOI:10.1177/15209156251362705

Pedro Gil, Judit Amigó, Ángel Ortiz-Zúñiga, Mónica Sánchez, Marcos Dos Santos, Fátima Cuadra, María José Abadias, Cristina Hernández, Rafael Simó, Olga Simó-Servat

{"title":"Impact of a Specialized Team in Diabetes on Glucometric Parameters and Efficiency Indicators During Hospital Admission in Medical Units.","authors":"Pedro Gil, Judit Amigó, Ángel Ortiz-Zúñiga, Mónica Sánchez, Marcos Dos Santos, Fátima Cuadra, María José Abadias, Cristina Hernández, Rafael Simó, Olga Simó-Servat","doi":"10.1177/15209156251362705","DOIUrl":null,"url":null,"abstract":"The study aimed to assess the impact of a specialized diabetes team (SDT) on medical units in terms of the improvement of glycemic parameters and hospital efficiency indicators such as length of stay (LOS) and readmissions. For this purpose, a prospective study including 289 patients under standard of care and 149 under the management of SDT was conducted. The SDT comprised two endocrinologists and two nurses specialized in diabetes. Patients under SDT management presented a significant reduction of both hypoglycemia prevalence 8.8% versus 17.6% (P = 0.013) and LOS (12.56 ± 11.94 vs. 16.28 ± 15.54; P = 0.005). In the multivariate analysis, hypoglycemia was independently related to LOS. In addition, the management by SDT resulted in a reduction in readmissions due to acute hyperglycemia at 3 months after the discharge (P = 0.019). We conclude that the management of diabetes by an SDT in medical units is an effective and cost-benefit strategy.","PeriodicalId":11159,"journal":{"name":"Diabetes technology & therapeutics","volume":" ","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes technology & therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15209156251362705","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

The study aimed to assess the impact of a specialized diabetes team (SDT) on medical units in terms of the improvement of glycemic parameters and hospital efficiency indicators such as length of stay (LOS) and readmissions. For this purpose, a prospective study including 289 patients under standard of care and 149 under the management of SDT was conducted. The SDT comprised two endocrinologists and two nurses specialized in diabetes. Patients under SDT management presented a significant reduction of both hypoglycemia prevalence 8.8% versus 17.6% (P = 0.013) and LOS (12.56 ± 11.94 vs. 16.28 ± 15.54; P = 0.005). In the multivariate analysis, hypoglycemia was independently related to LOS. In addition, the management by SDT resulted in a reduction in readmissions due to acute hyperglycemia at 3 months after the discharge (P = 0.019). We conclude that the management of diabetes by an SDT in medical units is an effective and cost-benefit strategy.

查看原文本刊更多论文

糖尿病专业小组对医疗单位住院期间血糖测量参数和效率指标的影响

本研究旨在评估糖尿病专科小组（SDT）在改善血糖参数和住院时间（LOS）和再入院等医院效率指标方面对医疗单位的影响。为此，我们进行了一项前瞻性研究，包括289例标准治疗组和149例SDT治疗组。SDT由两名内分泌专家和两名糖尿病专科护士组成。接受SDT治疗的患者低血糖患病率（8.8% vs. 17.6%）和LOS（12.56±11.94 vs. 16.28±15.54）均显著降低；P = 0.005)。在多变量分析中，低血糖与LOS独立相关。此外，SDT管理导致出院后3个月因急性高血糖再入院的人数减少（P = 0.019）。我们的结论是，在医疗单位管理糖尿病的SDT是一个有效的和成本效益的策略。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diabetes technology & therapeutics 医学-内分泌学与代谢

CiteScore

10.60

自引率

14.80%

发文量

145

审稿时长

3-8 weeks

期刊介绍： Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.